Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
about
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort
description
scientific article published on 17 October 2019
@en
name
Nivolumab Monotherapy and Nivo ...... heckMate 032 Randomized Cohort
@en
type
label
Nivolumab Monotherapy and Nivo ...... heckMate 032 Randomized Cohort
@en
prefLabel
Nivolumab Monotherapy and Nivo ...... heckMate 032 Randomized Cohort
@en
P2093
P1476
Nivolumab Monotherapy and Nivo ...... heckMate 032 Randomized Cohort
@en
P2093
Akin Atmaca
Christine L Hann
D Ross Camidge
David R Spigel
Filippo de Braud
Jon Zugazagoitia
Leora Horn
Margaret K Callahan
P304
P356
10.1016/J.JTHO.2019.10.004
P577
2019-10-17T00:00:00Z